Zhen-Yu Zhou1, Ya-Ke Liu, Hong-Lin Chen, Fan Liu. 1. Department of Orthopaedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
Abstract
OBJECTIVE: Evidence shows obesity is an important risk factor for knee osteoarthritis (OA). However, the dose-response relationship between body mass index (BMI) and knee OA risk is unclear. The purpose of the current study is to establish a nonlinear dose-response relationship between BMI and risk of knee OA. METHODS: The electronic database of PubMed, Web of Science, and translating research into practice (TRIP) database were searched. Observational studies for BMI and knee OA risk were included. Restricted cubic splines and generalized least-squares regression methods were used to model a potential curvilinear relationship and to make a dose-response meta-analysis. RESULTS: A total of 12 studies were included in the meta-analysis. A non-linear dose-response association between BMI and risk of knee OA was significant (P = 0.001). The relative risks were 1.59 (95% CI: 1.34-1.81), 3.55 (95% CI: 2.51-5.11), and 7.45 (95% CI: 4.19-13.13) when BMI was at the point of 25, 30, and 35 kg/m(2) compared with reference (22.5 kg/m(2) , the median value of the lowest category), respectively. Non-linear dose-response association was also significant in male and female subgroup. In male subgroup, the relative risks were 1.39 (95% CI: 0.99-1.92), 3.41 (95% CI: 2.07-5.48), and 5.71 (95% CI: 3.12-9.95) when BMI was at the point of 25, 30, and 32.5 kg/m(2) compared with reference, respectively. In female subgroup, the relative risks were 1.72 (95% CI: 1.51-1.99), 3.51 (95% CI: 2.65-4.51), and 4.72 (95% CI: 3.25-6.91) compared with reference when BMI was at the point of 25, 30, and 32.5 kg/m(2) compared with reference, respectively. Modest publication bias was found in the meta-analysis. However, sensitivity analysis showed a high stability for the result. CONCLUSIONS: The meta-analysis indicated that knee OA risk increased almost exponentially according with the increase of body mass index. Knee OA prevention will benefit from weight control.
OBJECTIVE: Evidence shows obesity is an important risk factor for knee osteoarthritis (OA). However, the dose-response relationship between body mass index (BMI) and knee OA risk is unclear. The purpose of the current study is to establish a nonlinear dose-response relationship between BMI and risk of knee OA. METHODS: The electronic database of PubMed, Web of Science, and translating research into practice (TRIP) database were searched. Observational studies for BMI and knee OA risk were included. Restricted cubic splines and generalized least-squares regression methods were used to model a potential curvilinear relationship and to make a dose-response meta-analysis. RESULTS: A total of 12 studies were included in the meta-analysis. A non-linear dose-response association between BMI and risk of knee OA was significant (P = 0.001). The relative risks were 1.59 (95% CI: 1.34-1.81), 3.55 (95% CI: 2.51-5.11), and 7.45 (95% CI: 4.19-13.13) when BMI was at the point of 25, 30, and 35 kg/m(2) compared with reference (22.5 kg/m(2) , the median value of the lowest category), respectively. Non-linear dose-response association was also significant in male and female subgroup. In male subgroup, the relative risks were 1.39 (95% CI: 0.99-1.92), 3.41 (95% CI: 2.07-5.48), and 5.71 (95% CI: 3.12-9.95) when BMI was at the point of 25, 30, and 32.5 kg/m(2) compared with reference, respectively. In female subgroup, the relative risks were 1.72 (95% CI: 1.51-1.99), 3.51 (95% CI: 2.65-4.51), and 4.72 (95% CI: 3.25-6.91) compared with reference when BMI was at the point of 25, 30, and 32.5 kg/m(2) compared with reference, respectively. Modest publication bias was found in the meta-analysis. However, sensitivity analysis showed a high stability for the result. CONCLUSIONS: The meta-analysis indicated that knee OA risk increased almost exponentially according with the increase of body mass index. Knee OA prevention will benefit from weight control.
Authors: Adam G Culvenor; David T Felson; Jingbo Niu; Wolfgang Wirth; Martina Sattler; Torben Dannhauer; Felix Eckstein Journal: Arthritis Care Res (Hoboken) Date: 2017-08 Impact factor: 4.794
Authors: Mukundan Attur; Svetlana Krasnokutsky; Alexander Statnikov; Jonathan Samuels; Zhiguo Li; Olga Friese; Marie-Pierre Hellio Le Graverand-Gastineau; Leon Rybak; Virginia B Kraus; Joanne M Jordan; Constantin F Aliferis; Steven B Abramson Journal: Arthritis Rheumatol Date: 2015-11 Impact factor: 10.995
Authors: M Attur; A Statnikov; J Samuels; Z Li; A V Alekseyenko; J D Greenberg; S Krasnokutsky; L Rybak; Q A Lu; J Todd; H Zhou; J M Jordan; V B Kraus; C F Aliferis; S B Abramson Journal: Osteoarthritis Cartilage Date: 2015-11 Impact factor: 6.576
Authors: Jacek A Kopec; Eric C Sayre; Philippe Fines; William M Flanagan; Claude Nadeau; Anya Okhmatovskaia; Michael C Wolfson Journal: Arthritis Care Res (Hoboken) Date: 2016-08 Impact factor: 4.794
Authors: Christine A Pellegrini; Jing Song; Rowland W Chang; Pamela A Semanik; Jungwha Lee; Linda Ehrlich-Jones; Daniel Pinto; Dorothy D Dunlop Journal: J Phys Act Health Date: 2015-11-06
Authors: Joseph A Zeni; Portia Flowers; Michael Bade; Victor Cheuy; Jennifer Stevens-Lapsley; Lynn Snyder-Mackler Journal: J Orthop Res Date: 2018-12-17 Impact factor: 3.494